Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Frame FM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Pathology; Jan2009, Vol. 217 Issue 2, p299-306, 8p
Autor:
Garnham R; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Geh D; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Nelson R; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Ramon-Gil E; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Wilson L; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Schmidt EN; Department of Chemistry, University of Alberta, Edmonton, AB, T6G 2G2, Canada.; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, T6G 2E1, Canada., Walker L; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Adamson B; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Buskin A; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Hepburn AC; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Hodgson K; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Kendall H; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Maitland N; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Coffey K; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Strand DW; Department of Urology, UT Southwestern Medical Center, Dallas, TX, USA., Robson CN; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Elliott DJ; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Heer R; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Macauley M; Department of Chemistry, University of Alberta, Edmonton, AB, T6G 2G2, Canada.; Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB, T6G 2E1, Canada., Munkley J; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Gaughan L; Newcastle University, Centre for Cancer, Newcastle University Translational and Clinical Research Institute, Newcastle, NE1 3BZ, UK., Leslie J; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK., Scott E; Newcastle University, Centre for Cancer, Newcastle University Biosciences Institute, Newcastle, NE1 3BZ, UK. emma.scott@newcastle.ac.uk.
Publikováno v:
Communications biology [Commun Biol] 2024 Mar 06; Vol. 7 (1), pp. 276. Date of Electronic Publication: 2024 Mar 06.
Autor:
Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Archer Goode E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Newcastle upon Tyne, UK., Livermore K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Putri Nangkana K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, North Yorkshire, UK., Bermudez A; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, USA., Jose Garcia Marques F; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, USA., McClurg UL; Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Thomas H; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Buskin A; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Hepburn A; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Arredondo HM; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Haider A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Singh S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Johnston EW; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Punwani S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Knight B; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McCullagh P; Department of Pathology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McGrath J; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Crundwell M; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Harries L; Institute of Biomedical and Clinical Sciences, Medical School, College of Medicine and Health, University of Exeter, Exeter, UK., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, UK.; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, North Yorkshire, UK., Whitaker H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Pitteri S; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, USA., Troyer DA; Cancer Biology and Infectious Disease Research Center, Eastern Virginia Medical School, Norfolk, VA, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK., Drake RR; Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, SC, USA., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, UK.
Publikováno v:
The Journal of pathology [J Pathol] 2023 Sep; Vol. 261 (1), pp. 71-84. Date of Electronic Publication: 2023 Aug 07.
Autor:
Scott E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hodgson K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Calle B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Turner H; Cellular Pathology, The Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne, NE1 4LP, UK., Cheung K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bermudez A; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Marques FJG; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Yo EC; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Islam K; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland., Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., McClurg UL; Institute for Integrative Biology, University of Liverpool, Liverpool, L69 7ZB, UK., Wilson L; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Thomas H; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Orozco-Moreno M; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Bastian K; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Arredondo HM; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Roustan C; Structural Biology Science Technology Platform, The Francis Crick Institute, NW1 1AT, London, UK., Gray MA; Sarafan Chem-H and Departemnt of Chemistry, Stanford University, 424 Santa Teresa St, Stanford, CA, 94305, USA., Kelly L; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Tolson A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Mellor E; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Hysenaj G; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Goode EA; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Garnham R; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Duxfield A; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Stopka-Farooqui U; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Haider A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Singh S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Johnston EW; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Punwani S; UCL Centre for Medical Imaging, Charles Bell House, University College London, London, UK., Knight B; NIHR Exeter Clinical Research Facility, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McCullagh P; Department of Pathology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., McGrath J; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Crundwell M; Exeter Surgical Health Services Research Unit, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK., Harries L; Institute of Biomedical and Clinical Sciences, Medical School, College of Medicine and Health, University of Exeter, Exeter, UK., Bogdan D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Westaby D; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Fowler G; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Flohr P; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Yuan W; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK., Sharp A; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., de Bono J; Division of Clinical Studies, The Institute of Cancer Research, London, SM2 5NG, UK.; Prostate Cancer Targeted Therapy Group, The Royal Marsden Hospital, London, SM2 5PT, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire, YO10 5DD, UK., Wisnovsky S; University of British Columbia, Faculty of Pharmaceutical Sciences, Vancouver, BC, V6T 1Z3, Canada., Bertozzi CR; Howard Hughes Medical Institute, 424 Santa Teresa St, Stanford, CA, 94305, USA., Heer R; Newcastle University Centre for Cancer, Translational and Clinical Research Institute, Paul O'Gorman Building, Newcastle University, Newcastle upon Tyne, NE2 4HH, UK.; Department of Urology, Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, UK., Guerrero RH; University of Zaragoza, Mariano Esquillor s/n, Campus Rio Ebro, Edificio I+D, Zaragoza, Spain; Fundación ARAID, 50018, Zaragoza, Spain.; Copenhagen Center for Glycomics, Department of Cellular and Molecular Medicine, University of Copenhagen, Copenhagen, Denmark., Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, V5Z 1M9, Canada.; Vancouver Prostate Centre, Vancouver, BC, V6H 3Z6, Canada., Leivo J; Department of Life Technologies, Division of Biotechnology, University of Turku, Turku, Finland.; InFLAMES Research Flagship Center, University of Turku, Turku, Finland., Whitaker H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, UK., Pitteri S; Canary Center at Stanford for Cancer Early Detection, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA., Wang N; The Mellanby Centre for Musculoskeletal Research, Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Elliott DJ; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK., Schumann B; The Chemical Glycobiology Laboratory, The Francis Crick Institute, NW1 1AT, London, UK.; Department of Chemistry, Imperial College London, W12 0BZ, London, UK., Munkley J; Newcastle University Centre for Cancer, Newcastle University Institute of Biosciences, Newcastle, NE1 3BZ, UK. Jennifer.munkley@ncl.ac.uk.
Publikováno v:
Oncogene [Oncogene] 2023 Mar; Vol. 42 (12), pp. 926-937. Date of Electronic Publication: 2023 Feb 01.
Autor:
Buhigas C; Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK., Warren AY; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, CB2 0QQ, UK., Leung WK; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK., Whitaker HC; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.; Molecular Diagnostics and Therapeutics Group, Division of Surgery and Interventional Sciences University College London, London, W1W 7TS, UK., Luxton HJ; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.; Molecular Diagnostics and Therapeutics Group, Division of Surgery and Interventional Sciences University College London, London, W1W 7TS, UK., Hawkins S; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK., Kay J; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.; Molecular Diagnostics and Therapeutics Group, Division of Surgery and Interventional Sciences University College London, London, W1W 7TS, UK., Butler A; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK., Xu Y; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK., Woodcock DJ; Oxford Big Data Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK., Merson S; The Institute of Cancer Research, London, SW7 3RP, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, YO10 5DD, North Yorkshire, UK., Sahli A; Oxford Big Data Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK., Abascal F; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK., Martincorena I; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK., Bova GS; Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Center, 33014, Tampere, FI, Finland., Foster CS; HCA Laboratories, London, WC1E 6JA, UK., Campbell P; Cancer, Ageing and Somatic Mutation, Wellcome Trust Sanger Institute, Hinxton, CB10 1RQ, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, YO10 5DD, North Yorkshire, UK., Neal DE; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK., Massie CE; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.; Department of Oncology, University of Cambridge, Cambridge, CB2 0XZ, UK., Lynch AG; Cancer Research UK Cambridge Institute, Cambridge, CB2 0RE, UK.; School of Medicine/School of Mathematics and Statistics, University of St Andrews, St Andrews, KY16 9AJ, UK., Eeles RA; The Institute of Cancer Research, London, SW7 3RP, UK.; Royal Marsden NHS Foundation Trust, London and Sutton, SM2 5PT, UK., Cooper CS; Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK.; The Institute of Cancer Research, London, SW7 3RP, UK., Wedge DC; Oxford Big Data Institute, University of Oxford, Old Road Campus, Oxford, OX3 7LF, UK.; Manchester Cancer Research Centre, University of Manchester, Manchester, M20 4GJ, UK., Brewer DS; Norwich Medical School, University of East Anglia, Norwich, Norfolk, NR4 7TJ, UK. d.brewer@uea.ac.uk.; Earlham Institute, Norwich, NR4 7UZ, UK. d.brewer@uea.ac.uk.
Publikováno v:
Molecular cancer [Mol Cancer] 2022 Sep 22; Vol. 21 (1), pp. 183. Date of Electronic Publication: 2022 Sep 22.
Autor:
Archer LK; Cancer Research Unit, Department of Biology, University of York, Heslington, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, UK., Walker HF; Cancer Research Unit, Department of Biology, University of York, Heslington, UK., Droop AP; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., McDonald GLK; Cancer Research Unit, Department of Biology, University of York, Heslington, UK., Kucko S; Cancer Research Unit, Department of Biology, University of York, Heslington, UK., Berney DM; Department of Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, UK., Mann VM; Cancer Research Unit, Department of Biology, University of York, Heslington, UK., Simms MS; Department of Urology, Castle Hill Hospital, Cottingham, UK., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, UK.
Publikováno v:
FEBS open bio [FEBS Open Bio] 2022 Jul; Vol. 12 (7), pp. 1365-1387. Date of Electronic Publication: 2022 May 06.
Autor:
Quattrini L; Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy., Sadiq M; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, West Yorkshire BD7 1DP, UK., Petrarolo G; Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy., Maitland NJ; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire YO10 5DD, UK., Frame FM; Cancer Research Unit, Department of Biology, University of York, Heslington, North Yorkshire YO10 5DD, UK., Pors K; Institute of Cancer Therapeutics, School of Pharmacy and Medical Sciences, Faculty of Life Sciences, University of Bradford, West Yorkshire BD7 1DP, UK., La Motta C; Department of Pharmacy, University of Pisa, Via Bonanno 6, 56126 Pisa, Italy.; CISUP, Centre for Instrumentation Sharing, University of Pisa, Lungarno Pacinotti 43, 56128 Pisa, Italy.
Publikováno v:
Biomedicines [Biomedicines] 2020 Dec 04; Vol. 8 (12). Date of Electronic Publication: 2020 Dec 04.